Status:
UNKNOWN
Serum Maresin-1 Predicts the Severity of Severe Acute Pancreatitis
Lead Sponsor:
Weiqin Li
Conditions:
Pancreatitis, Acute
Eligibility:
All Genders
18-75 years
Brief Summary
This is a retrospective study about serum Maresin-1 level in different severe acute pancreatitis patients. The investigators want to study the correlation between the level of serum Maresin-1 and the ...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Severe Acute Pancreatitis
- Biliary pancreatitis
- 7 days of the onset
Exclusion
- Surgical patients
- Serious diseases and infection
- Alcoholic pancreatitis
- Hypertriglyceridemia pancreatitis
- Disorder of Glucolipide Metabolism：diabetes mellitus, hypertriglyceridemia, BMI\>30
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03364920
Start Date
January 1 2018
End Date
January 1 2020
Last Update
December 7 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.